This document provides information about the antipsychotic medication Fluanxol Depot, including its prescribed dosage of 20 mg/ml per solution. It lists the drug's classification, purpose for taking it to alter dopamine levels in the central nervous system, and potential therapeutic effects and side effects to monitor for like changes in liver enzymes, blood glucose, serum prolactin, and extrapyramidal symptoms. The nursing responsibilities are outlined such as assessing mental status, vital signs, weight, and bowel function and monitoring for side effects during the medication regimen.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
570 views4 pages
Prescribed Medication: Information Leaflet Prior
This document provides information about the antipsychotic medication Fluanxol Depot, including its prescribed dosage of 20 mg/ml per solution. It lists the drug's classification, purpose for taking it to alter dopamine levels in the central nervous system, and potential therapeutic effects and side effects to monitor for like changes in liver enzymes, blood glucose, serum prolactin, and extrapyramidal symptoms. The nursing responsibilities are outlined such as assessing mental status, vital signs, weight, and bowel function and monitoring for side effects during the medication regimen.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 4
Prescribed Medication Prescribed dosage, Frequency and Route of Administration:
Brand Name: Fluanxol Depot
Therapeutic Dosage: 20 mg/ml per solution Generic Name: Flupentixol decanoate Drug Classification Purpose/ Reasons for taking Patient Teaching Nursing Responsibilities (General Action) the Medication Therapeutic class: Instruct patient to Assess mental status Antipsychotic Alters the effects of take as directed. If a dose (orientation, mood, Pharmacologic Class: dopamine in the CNS. Has is missed, omit and take behavior) before and thioxanthenes some anticholinergic and next dose as scheduled. periodically during Laboratory Tests/Results alpha-adrenergic blocking Discontinuation should be therapy. activity. Relevant to the Medication gradual; abrupt Monitor BP (sitting, Monitor CBC and liver Therapeutic Effect(s): discontinuation may standing, lying), ECG, function tests periodically Diminished signs and cause withdrawal pulse, and respiratory rate during treatment. May cause symptoms of schizophrenia. symptoms (nausea, before and frequently ↑ AST, ALT, and alkaline vomiting, anorexia, during the period of dose phosphatase. diarrhoea, rhinorrhoea, adjustment. May cause Q- Monitor blood sweating, myalgias, T prolongation. glucose prior to and paraesthesias, insomnia, Observe carefully periodically during restlessness, anxiety, when administering oral therapy. May cause agitation, vertigo, feelings medication to ensure that hyperglycemia. of warmth and coldness, medication is actually Monitor serum tremor). Symptoms begin taken and not hoarded. prolactin prior to and within 1 to 4 days of Assess weight and periodically during withdrawal and abate BMI initially and therapy. May cause ↑ within 7 to 14 days. throughout therapy. serum prolactin levels. Advise patient to Assess fluid intake May cause false- read Patient and bowel function. positive pregnancy tests. Information leaflet prior Increased bulk and fluids to starting therapy and in the diet help minimize with each Rx refill in case constipation. of changes. Monitor for onset of Inform patient of akathisia (restlessness or possibility of desire to keep moving) extrapyramidal symptoms and extrapyramidal side and tardive dyskinesia. effects Caution patient to report (parkinsonian– difficulty these symptoms speaking or swallowing, immediately to health loss of balance control, care professional. pill rolling, mask-like Advise patient to face, shuffling gait, change positions slowly rigidity, to minimize orthostatic tremorsdystonic– muscle hypotension. spasms, twisting motions, Medication may twitching, inability to cause drowsiness. Caution move eyes, weakness of patient to avoid driving or arms or legs) every 2 mo other activities requiring during therapy and 8–12 alertness until response to wk after therapy has been medication is known. discontinued. Reduction Advise patient to in dose or discontinuation notify health care of medication may be professional of all Rx or necessary. Benztropine or OTC medications, diphenhydramine may be vitamins, or herbal used to control these products being taken and symptoms. to consult with health care Monitor for tardive professional before taking dyskinesia (uncontrolled other medications. rhythmic movement of Caution patient to mouth, face, and avoid concurrent use of extremities; lip smacking alcohol and other CNS or puckering; puffing of depressants. cheeks; uncontrolled Instruct patient to chewing; rapid or worm- notify health care like movements of professional promptly if tongue). Report sore throat, fever, unusual immediately; may be bleeding or bruising, rash, irreversible. weakness, tremors, visual Monitor for disturbances, dark- development of colored urine, or clay- neuroleptic malignant colored stools occur. syndrome (fever, Instruct patient to respiratory distress, avoid sun exposure and to tachycardia, seizures, wear protective clothing diaphoresis, arrhythmias, and sunscreen when hypertension or outdoors. hypotension, pallor, Advise patient to tiredness, severe muscle notify health care stiffness, loss of bladder professional of control). Report medication regimen immediately. before treatment or Monitor for surgery. symptoms related to Advise female hyperprolactinemia patients to notify health (menstrual abnormalities, care professional if galactorrhea, and sexual pregnancy is planned or dysfunction). suspected or if breast feeding or planning to breast feed.